Most Read Articles
one year ago
Cetuximab as third line therapy provided survival benefits and maintained quality of life in patients with metastatic colorectal cancers (mCRC) who responded unsuccessfully to prior chemotherapy, a study conducted in a single institution has shown.
Jairia Dela Cruz, 6 months ago
Regimens containing sofosbuvir and velpatasvir are the best option for treating patients with hepatitis C virus (HCV) genotype 3 infection, according to the results of a network meta-analysis. Furthermore, ribavirin should be considered in select patients as the agent produces significant increases in sustained virological response (SVR) rates.
one year ago
Daily oral HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil fumarate may be safe in hepatitis B virus (HBV)-infected individuals, a study reported.
Pearl Toh, one year ago
Treatment with eluxadoline, a new oral medication, relieved two major symptoms of irritable bowel syndrome with diarrhoea (IBS-D) — abdominal pain and diarrhoea, according to a study based on two phase III randomized controlled trials. [N Engl J Med 2016;374:242-253]

The role of direct-acting antivirals in the new era of hepatitis C treatment

5 months ago
At the recent Annual Scientific Congress of the Malaysian Society of Gastroenterology and Hepatology (GUT 2016), held at Shangri-La Hotel, Kuala Lumpur, an expert from Hong Kong spoke on the role of direct-acting antivirals as well as pan-genotypic agents that are set to revolutionize hepatitis C treatment.
Editor's Recommendations
Most Read Articles
one year ago
Cetuximab as third line therapy provided survival benefits and maintained quality of life in patients with metastatic colorectal cancers (mCRC) who responded unsuccessfully to prior chemotherapy, a study conducted in a single institution has shown.
Jairia Dela Cruz, 6 months ago
Regimens containing sofosbuvir and velpatasvir are the best option for treating patients with hepatitis C virus (HCV) genotype 3 infection, according to the results of a network meta-analysis. Furthermore, ribavirin should be considered in select patients as the agent produces significant increases in sustained virological response (SVR) rates.
one year ago
Daily oral HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil fumarate may be safe in hepatitis B virus (HBV)-infected individuals, a study reported.
Pearl Toh, one year ago
Treatment with eluxadoline, a new oral medication, relieved two major symptoms of irritable bowel syndrome with diarrhoea (IBS-D) — abdominal pain and diarrhoea, according to a study based on two phase III randomized controlled trials. [N Engl J Med 2016;374:242-253]